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Abstracts / Urological Science 26 (2015) S1eS25S10Conclusion: Learning curve for every 200 cases of RALP showed
signiﬁcantly less blood loss and blood transfusion rate. The keys to
prevent complication was preoperation evaluation meticulously and a
dedicated robotic team to do RALP intraoperatively. Early diagnosis and
management of complication is paramount in patients have any
deviation from the normal postoperative course and clinical care
pathway.
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”ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY FOR
PREOPERATIVELYSUSPICIOUS PROSTATE CANCER PATIENTS IN
EXPERIENCE OF 50 CASES- IS A NOVEL INDICATION FOR ROBOTIC
SURGERY? ”
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Chang 2, John Wang M.D. 3, Siu-Wan Hung M.D. 4. 1Division of Urology,
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Taiwan; 2Department of Research, Taichung Veterans General Hospital,
Taichung, Taiwan; 3Department of Pathology, Taichung Veterans General
Hospital, Taichung, Taiwan; 4Department of Radiation, Taichung Veterans
General Hospital, Taichung, Taiwan
Purpose: To report the experience of 50 cases of robotic-assisted laparo-
scopic radical prostatectomy (RALP) by single surgeon (YCOU) for suspi-
cious prostate cancer preoperatively.
Materials and Methods: Prostate cancer was suspected and RALP was
performed in 50 cases from Feb. 2012 to March 2015. The mean age was
64.21-year-old. The PSA level range 2.5-75 ng/dl (mean: 15) preopera-
tively. Transrectalsonoguiding biopsy (TRUS) of prostate was done in 41
(82%) cases (once: 26 cases, twice: 12 cases, thrice: 2 cases and four times:
one case) and 9 (18%) cases didn't receive biopsy preoperatively. TRUS
pathology revealed prostatic intraepithelial neoplasia (PIN) in 5 cases
(high grade: 3, low grade: 2), atypical hyperplasia in one case and nodular
hyperplasia (with or without inﬂammation) in 35 cases. All patients have
lower urinary tract symptom(LUTS). MRI was performed in 45 cases and
showed prostate index (PI)-Rad grade III in 36 cases and PI-Rad grade IV in
9 cases. Patients with full understanding signed informed consent for ro-
botic radical prostatectomy before operation after discussion with
operator.
Results: Operation parameters included console time 112.6 min, blood loss
92.6 ml and the mean prostate volume was 63.69 ml. No blood transfusion
in all patients. Two Clavien system, grade I complications (Ileus in one case
and intraoperative urinary bladder perforation with repair in one) was
noted. Whole-mount step section of prostate pathology disclosed adeno-
carcinoma in 19 cases (38%), PIN (high grade: 6, low:5) in 11 cases, atypical
hyperplasia in 4 cases and nodular hyperplasia (with or without inﬂam-
mation) in 16 cases ( 32%). pT2 in 13 cases and pT3 in 6 cases was found.
Two positive surgical margin in two cases. Nineteen cases of prostate
cancer showed Gleason score (GS) 5 in 3 cases, GS 6 in 9 cases, GS 7 in 6
cases and GS 8 in one case. The tumor volume ranged 0.1 ml to 12 ml with
mean 3.59 ml. The tumor percentage in whole prostate was 8.2% (0.1%-
65%). Preoperatively urodynamic study revealed voided urine volume (VV)
208 ml, maximal/mean ﬂow rate 10.85/4.5 ml/sec and post-void residual
urine volume (PVR) 72.42 ml. Postperatively urodynamic study revealed
voided urine volume (VV) 234 ml, maximal/mean ﬂow rate 20.66/11.4 ml/
sec and post-void residual urine volume (PVR) 9.36 ml. The international
prostate symptom score (IPSS) was statistically signiﬁcant reduced from
19.82 to 2.67 and also bother score decreased from 4 to 0.125. All patients
experienced continence of urination in mean 10.7 post-operative day
(POD) ( POD 0-40). Two patient with biochemical recurrence (BCR) was
noted.
Conclusion: Robotic-assisted laparoscopic radical prostatectomy for sus-
picious prostate cancer preoperatively and moderate LUTS disclosed 38%
with adenocarcinoma and 30% of PIN or atypical hyperplasia. The subset of




THE RELEVANCE OF IMMUNE RESPONSES ON PARTIAL BLADDER
OUTLET OBSTRUCTION AND REVERSAL
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Purpose: Partial bladder outlet obstruction (PBOO) causes tissue inﬂam-
mation, signiﬁcantly increased systemic oxidative stress markers, and the
proliferation of circulating myeloid-derived suppressor cells. Since these
systemic immunologic responses are associated with PBOO, this study
investigated the regulatory mechanism of inﬂammation and helper T cells.
Materials and Methods: Surgical PBOO was performed in four groups of
rats, including control (C), obstruction at 2 (O2) and 4 (O4) weeks, and at 4
weeks after relief of PBOO (R4) (n ¼ 6 each). Levels of urinary prosta-
glandin metabolite (PGEM), expressions of inﬂammatory cytokines (IL-6
and IL-17) in the bladder, and levels of peripheral blood regulatory T cells
(Treg cells) and TGF-b1 were assessed by immuno-histochemistry, ﬂow
cytometry, or ELISA.
Results: Levels of urinary PGEM, bladder IL-17, and peripheral Treg cell
(Foxp3) and TGF-b1 all signiﬁcantly increased at 2 and 4 weeks after PBOO.
PGEM, IL-17, and Treg cells (Foxp3) were down-regulated after relief of
PBOO, while TGF-b1 level further increased.
Conclusion: Transient PBOO triggers an acute, reversible increase in in-
ﬂammatory cytokines and Treg. The distinct dynamics of individual in-
ﬂammatory markers suggest that they may be potential parameters for
monitoring bladder inﬂammation.Renal transplantation
PD6-2:
EVALUATION THE RELATIONSHIP AND POST-OPERATIVE GFR BETWEEN
THE LIVING DONOR AND THE RECIPIENTS IN KIDNEY TRANSPLANTATION
Guang-Heng Chen, His-Hsien Wang, Po-Jen Hsiao, Yi-Huei Chang, Shen-
Wei Li, Chi-Ping Huang, Hsi-Chin Wu, Chao-Hsiang Chang. Department
of Urology, China Medical University Hospital, Taichung, Taiwan
Purpose: This study evaluate the relationship and post-operative GFR
between the living donor and the recipients in kidney transplantation. A 5-
year review of living donor renal transplants in a single transplant center
was performed.
Materials and Methods: Between January 2010 until February 2015, a
total of 49 living donor KTs were performed at China Medical University
Hospital. Relationship between donor and recipient and graft survival and
changes in GFR during a 5-year period in a single center were retrospec-
tively analyzed.
Results: These 49 living donor kidneys transplants represent 52% of all
transplants performed during this 5-year review. The recipients' kidney
involved from sibling donation (22.4%, mean age 37.18), parents donation
(32.7%, mean age 27.56), offspring donation (22.4%, mean age 54.27) and
spouse donation (22.4%, mean age 49.09). The GFR of the recipients had
signiﬁcant difference between these four groups during the following
periods. The mean last follow-up postoperative GRF of the recipients was
77.71ml/min for offspring donors, 57.81ml/min for parents donors,
65.91ml/min for sibling donors and 42.91ml/min for the spouse donors
respectively (p¼ 0.04). The numbers of female donors were more than the
male donors(32 vs 17). Two grafts loss were noted all in the spouse living
donor population due to infection (CMV virus and urinary tract infection).
Abstracts / Urological Science 26 (2015) S1eS25 S11Conclusion: This review of center-speciﬁc data shows that the relationship
of the donor to their recipient hasmake a signiﬁcant difference on the post-
operative GFR and graft loss of the recipients. The recipients' kidney
donated from the spouse the hadworst GFR compared to the others groups.Other
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APPLICATION OF RESONANCE METALLIC STENTS FOR BENIGN AND
MALIGNANT URETERAL OBSTRUCTION: LONG-TERM FOLLOW-UP
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Purpose: To evaluate the outcomes of the metallic Resonance® ureteral
stent and clarify the risk factors that lead to stent failure. In the present
study, we present 5 years of our experiences with the use of a Resonance
stent for malignant and benign ureteral obstruction.
Materials and Methods: We retrospectively identiﬁed and analyzed the
records of all patients in whom Resonance® Metallic Ureteral Stent was
placed between early 2009 and late 2014 in our hospital. We performed a
descriptive analysis of key outcomes, including the failure and stenting
duration, deﬁned as the time from initial stent placement to last stent
failure or patient death.
Results: A total of 52 metallic stents were placed in 36 patients, including
44 (84.6%) with malignant and 8 (15.4%) with a benign etiology. Maximum
follow-up was 58 months (mean 14.7, median 8.5, IQR 14.9). Stent failure
occurred in 10 patients (19.2%). The re-occlusion rate was signiﬁcantly
higher in the subgroup with urinary bladder invasion malignancy during
Resonance stent insertion (p ¼ 0.035). Patients who had had previous
radiation therapy had a lower patency rate in comparison with non-radi-
ation patients (p ¼ 0.001), especially in patients with Resonance stent
placement more than one year (p ¼ 0.018). And the 50% patency rate with
52 stents was 10 months.
Conclusion: The Resonance metallic stent could be safely applied for those
malignant or benign ureteral obstructions. For malignant ureteral
obstruction, previous radiation therapy is a risk factor for stent failure,
especially for those with long-term stent placement. We also suggested
revision of Resonance metallic stent every one year to keep stent patency
and prevent stent complications.
PD6-4:
LESS PAIN PERCEIVED IN TRANSRECTAL ULTRASOUND OF PROSTATE
USING MICRO-CONVEX TRANSDUCER THAN BI-PLANED LINEAR
TRANSDUCER
Pei-Shan Yang, Yu-Hsiang Lin, Chen-Pang Hou, Yu-Chao Hsu, Chien-Lun
Chen, Ke-Hung Tsui, Phei-Lang Chang. Division of Urology, Department of
Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan
Purpose: Evaluate the difference in the subjective in pain of using different
probes for transrectal ultrasound of prostate Material and Method: From
July 2014 to December 2014, patients undergoing transrectal ultrasound of
prostate (TRUS) were randomly divided into two groups, using two
different probes. A visual analogue (VAS) was used to evaluate the sub-
jective perception of pain in these patients.
Results: A signiﬁcant difference was found in VAS between the two
groups. The patient felt less pain during TRUS examination when using
micro convex transducer. Besides, patients with external hemorrhoid,
longer prostate sagittal length, and artifacts caused by stool were all found
to be associated with more pain. The usage of micro convex transducer can
help to reduce the pain for the patients with external hemorrhoids,a Dr. Hsu and Wang contribute equally to this manuscript and serve as co-ﬁrst
authors.whereas there was no difference of pain perception when the patient has
previous rectal surgery or artifacts caused by stool.
Conclusion: We identiﬁed the factors of pain associated with TRUS. Micro
convex transducer caused less pain associated TRUS than Bi-planed linear
transducer.
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EFFECT OF LOCAL ANESTHESIA FOR RIGID CYSTOSCOPY, HOW LONG IS
LONG ENOUGH: INITIAL DATA OF RANDOMIZING 34 PATIENTS
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Chiang, Meng-Yi Yan, Sheng-Hsien Huang, Chun-Chi Chen, Kuo-Hsuan
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Purpose: This study was done to compare the length and form of anes-
thesia that is suitable for patients undertaking rigid cystoscopy procedure
under local anesthesia.
Materials and Methods: From September 2014 to March 2015, a single
Fellow surgeon performed removal of double-J catheter with rigid
cystoscopy on 34 patients whom were randomized into two groups. One
group received intra-uretheral injection of 4% xylocaine (2 minutes) with
addition of 2% xylocaine jelly (1 minute) and another group with single
dose of intra-uretheral injection of 4% xylocaine (3 minutes). Both groups
received same amount of total anesthesia time (3 minutes). Several factors
were used to analyze the effectiveness of local anesthesia (difference of pre
and post-operative blood pressure and heart rate, VAS score, and patient's
own description). Factors that may inﬂuence the effectiveness of local
anesthesia were also recorded (form of anesthesia, length of anesthesia,
BMI, depression angle of bladder neck, age, and any cystoscopy ﬁnding).
Bladder neck depression anglewere estimated by recording the cystoscopy
insertion length and the actual depression when entering the bladder.
Trigonometry formula for angle using inverse sin was used to estimate the
depression angle.
Results: Thirty-four patients were included in this initial study. Initial data
showed that decrease anesthesia time with liquid xylocaine, BMI, age and
bladder neck depression angle of more than 30 degrees is associated with
increase pain (increase in VAS and heart rate). All patients still experienced
soreness even with increase length of anesthesia.
Conclusion: Studies have shown that a minimum of 5 minutes will be
needed for rigid cystoscopy examination. Due to our current environment
which demands maximizing efﬁciency without compromising patients'
priorities, the use of adequate form and length of anesthesia should be a
concern. Our initial data showed us that a liquid anesthesiawith either 2 or
4% xylocaine with a minimum of 3 minutes is sufﬁcient in performing rigid
cystoscopy examination under local anesthesia.
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BLADDER AUGMENTATION IN KETAMINE ASSOCIATED CYSTITIS
Wei-Ting Kuo 1, Hua-PinWang 1, Tsan-Jung Yu 1, Victor C. Lin 1,2. 1Department
of Urology, E-Da Hospital, Kaohsiung, Taiwan; 2 School of Medicine for
International Students, I-Shou University, Kaohsiung, Taiwan
Purpose: Ketamine associated cystitis presented with severe dysuria,
frequency, urgency, lower abdominal pain and gross hematuria. Due to its
pathologic damage, the ﬁlling bladder volume is decreased. In our hospital
we performed bladder augmentation in 4 cases of ketamine associated
cystitis from 2004 to 2013.
Materials and Methods: All 4 patients was ketamine abuser and diag-
nosed by clinical symptoms and cystoscopic examination of ulceration
with severe diffuse hemorrhage and low bladder capacity from 2004 to
2013. They all received bladder augmentation. The data on demographics,
clinical characteristics, and patient outcomes were collected. All the data
were yielded retrospectively.
Results: Total of 4 patients with ketamine associated cystitis received
bladder augmentation at E-Da tertiary medical center from 2004 to 2013.
Male patients were predominant (male : female ¼ 3:1). The average age at
operation is 29.75. ( ranged 28-32 ) The average ketamine abuse time is
9.25 years. ( ranged 8-11 ) After bladder augmentation of surgery, the post-
